To cite this article: Espitia Jaimes C, Fish RJ, Neerman-Arbez M. Local chromatin interactions contribute to expression of the fibrinogen gene cluster. J Thromb Haemost 2018; 16: 2070-82.
Introduction
Fibrinogen, the soluble precursor of fibrin, is a coagulation factor with a central role in blood clotting, platelet aggregation and thrombus formation [1] . Fibrinogen is abundant in plasma and varies from about 1.5 to 3.5 g L À1 in the healthy population [2] . A small number of genetic variants have been linked to plasma fibrinogen levels [3] . Understanding the source of plasma fibrinogen variability is a clinically relevant goal because high circulating fibrinogen levels are associated with increased risk of cardiovascular events [4, 5] .
Fibrinogen is an acute phase protein synthesized by hepatocytes as a hexameric protein assembled from two copies of three polypeptides (Aa, Bb, c) 2 . These are encoded by three genes (FGB-FGA-FGG), that are clustered within a 65 kilobase region on human chromosome 4 (4q23-q32) [6] . Remarkably, this configuration is conserved among tetrapods. Expression of the fibrinogen genes is coordinated [2, 6] , and the mechanism for this control appears to reside in the activity of proximal promoters and local enhancer elements. Four enhancers, CNC12, PFE2, E3 and E4, have been identified within the fibrinogen gene cluster [3, 7] . These regulatory sequences bind common transcriptional regulators and are delineated by active chromatin histone marks in fibrinogen-expressing cells. Interestingly, the fibrinogen cluster is flanked by CCCTC-binding factor (CTCF) interaction sites. CTCF is a broadly expressed zinc-finger protein that binds DNA and has a role in insulating genomic regions [8, 9] . Therefore, the fibrinogen gene cluster could represent a regulatory unit where regulatory elements interact and contribute to coordinated expression.
Chromatin structure plays a pivotal role in the regulation of gene expression in eukaryotes [10] . Chromatin is not static in structure but can fold to bring regulatory elements (enhancers and insulators) into proximity with target genes or other regulatory elements. Chromatin loops are the result of these long-range interactions [11, 12] .
Mammalian genomes are folded in a hierarchy of compartments: topologically associating domains (TADs), subTADs and looping interactions [13] . Mammalian TADs are, on average, a megabase long and represent looped chromosomal units within which sequences can preferentially contact each other, favoring common transcriptional regulation [14] [15] [16] . Contact maps of the human genome have allowed the annotation of nearly 10 000 loops, which typically lie between CTCF motifs found in a convergent orientation, as predicted by the loop extrusion model [17] . This finding highlights a role for CTCF in chromosomal structure and chromatin folding.
Looping of the human genome has been demonstrated using chromosome conformation capture (3C)-based technologies. They enable detection of physical proximity between segments of chromatin. The original 3C technology interrogates chromatin interactions between selected pairs of sequences in a region of interest [18, 19] . If regulatory element interactions, for example promoter-enhancer proximity, are to be interrogated, prior knowledge of these sequences in the selected genomic region is required [16] . The 3C-derived genomics methods [20] have provided detailed evidence of chromosome territories [21] , the role of CTCF and cohesin in mediating TAD looping [22, 23] and regulatory element contact [24] . Furthermore, they are now used in molecular medicine, helping interpretations of disease-associated variants [25] and improving our ability to predict the possible functional consequences of genetic variation on chromosomal architecture [26] .
The impact of deletion of CTCF interactions has been addressed. In locus-specific studies, for example the b-globin locus, CTCF was deleted in fetal liver cells in a conditional knockout mouse model. This demonstrated that CTCF is involved in chromatin architecture [22] . Recently, using an auxin-inducible degron system in mouse embryonic stem cells, it was shown that CTCF is required for looping between CTCF sites and for the maintenance of TADs [27] .
In the present study we performed loss-of-function and restoration-of-function experiments in HepG2 cells, using CRISPR-Cas9 genome editing to delete and reintroduce CTCF interaction sites at one boundary of the fibrinogen cluster. The 3C method was used to examine the spatial organization of chromatin in the human fibrinogen locus in cells that express or do not express fibrinogen and in CTCF site-edited cell lines. We investigated if local chromatin architecture influences fibrinogen gene expression and fibrinogen protein production. We show that fibrinogen gene expression relies on precise chromatin interactions. Our results provide a new mechanism to understand coordinate fibrinogen gene expression that may also control the expression of other clustered genes.
Materials and methods
Chromosome conformation capture 1 9 10 7 HepG2, HEK-293T, CTCF3 deleted (ΔCTCF3), CTCF4 deleted (ΔCTCF4), double deleted (ΔCTC F3 + 4), ΔCTCF3 rescue (ΔCTCF3R), ΔCTCF4 rescue (ΔCTCF4R) and double rescue (ΔCTCF3 + 4R) cell lines were treated, and data analyzed according to the 3C-qPCR method [28] with small modifications. Cells were crosslinked with 1.5% formaldehyde (Sigma-Aldrich, Saint Louis, MO, USA) for 10 min at room temperature and lysed in 5 mL of cold lysis buffer (10 mM Tris-HCl, pH 7.5; 10 mM NaCl; 0.2% NP-40; 19 complete protease inhibitor [Roche, Mannheim, Germany]). Chromatin fragmentation was achieved by digesting nuclei with 400 U of NlaIII (New England Biolabs, Ipswich, MA, USA) to give an average fragment size of about 500 bp. Digestion efficiency was assessed using primers that amplify across each NlaIII site of interest (Table S1 ): % restriction = 100-100/2^((CtR-CtC) Digested -(CtR-CtC) Undigested). Interacting fragments were ligated under diluted conditions with 200 U of T4 DNA ligase (New England Biolabs) for 4 h at 16°C and de-crosslinked at 65°C overnight. The 3C templates were purified by phenol-chloroform extraction.
Real-time PCR quantifications of ligation products were performed in a StepOnePlus TM (Applied Biosystems, Foster City, CA, USA) Real-Time PCR System using the KAPA SYBR FAST qPCR Master Mix and specific primers for every fragment of interest (Table S2) . For each ligation product, a digested and re-ligated bacterial artificial chromosome (BAC RP11-111A7), covering the fibrinogen gene cluster and control regions analyzed, was used as a control template. A constant primer and a test primer were used in each reaction. Standard curves using serial dilutions of control templates were performed to test amplification efficiency. The 3C-qPCR data were normalized to a loading control using internal primers amplifying a region of the GAPDH gene. For each 3C assay, using a pair of test/constant primers localized in a locus that contains a ubiquitously expressed gene, ERCC3 [22] , control interaction frequencies were also assessed (Table S3) .
CRISPR-Cas9-mediated genome editing CTCF3 and CTCF4 interaction sites flanking the telomeric end of the human fibrinogen gene cluster were edited using CRISPR-Cas9-based genome editing. They were identified by factorbook [29] and the UCSC genome browser display (http://genome.ucsc.edu) of ENCODE consortium ChIP-seq and ChIA-PET datasets [30] . ENCODE datasets for CTCF and RAD21 ChIP-seq in HepG2 cells, and CTCF ChIA-PET in other cells, were contributed by the Bernstein, Myers, Stamatoyannopoulos, Iyer, Ruan and Snyder laboratories. Single guide RNAs (sgRNAs) were designed to direct the Cas9 nuclease to two sequences for each CTCF site (Figures S1 and S2). Plasmids based on pSpCas9(BB)-2A-GFP (Addgene plasmid:48138, contributed by the Zheng laboratory) [31] were developed for expression of sgRNAs, along with a Cas9-2A-EGFP fusion transcript, leading to separate expression of Cas9 and EGFP from the same transcript. HepG2 cells were co-transfected with combinations of plasmids, using Fugene HD reagent (Roche), to drive target site cleavage in the presence of ssDNA oligonucleotides as homology-directed repair (HDR) templates ( Figures S1 and S2 ). EGFP-positive cells were clonally sorted into 96-well plates by flow cytometry 2 days post-transfection, and cultured. Cell lines were genotyped by PCR using the Guide-it Mutation Detection Kit (TAKARA Bio, Mountain View, CA, USA). Clones with bi-allelic edits, demonstrating the expected 35 and 31 bp deletions for CTCF3 and CTCF4 sites, respectively, were confirmed by Sanger sequencing. To reintroduce the CTCF interaction sites of CTCF3 and CTCF4, further pSpCas9(BB)-2A-GFP-based plasmids were developed to target the previously edited region, with ssDNA oligonucleotides for HDR. Transfections and clone identification were performed as for deletion clones. (Table S4 ). Fibrinogen protein production was measured as a ratio of fibrinogen secreted into cell-conditioned medium (ELISA) divided by total cell protein measured with a small-scale Bradford protein assay, as described previously [33] .
Interleukin-6, tumor necrosis factor alpha and lipopolysaccharide treatment
HepG2 and HepG2 ΔCTCF4 cells were cultured for 18 h post-seeding. Recombinant human interleukin-6 (IL-6) (Life Technologies) was added to the cell media at a concentration of 50 ng/ml, tumor necrosis factor alpha (TNF-a) (R & D Systems, Minneapolis, MN, USA) at 10 ng mL À1 and lipopolysaccharide (LPS) (Sigma) at 100 ng mL À1 . Non-treated and treated cells were collected 24 h following exposure to IL-6, TNF-a or LPS prior to the 3C protocol and RNA extraction and quantification. In TNF-a-treated cells b-actin levels increased. We therefore used selenocysteine lyase (SCLY) gene expression [34] as a control for samples treated with IL-6, TNF-a and LPS (Table S4 ). From our SCLY qPCR standard curve, TNF-a treatment gave a 1.4-fold increase in SCLY (less fold-change than b-actin). Normalization of fibrinogen expression using this control is not optimal, but the decrease in fibrinogen expression seen with TNFa treatment cannot be explained by a normalization artefact of increased SCLY.
Results
Chromatin interactions occur at the edges of and within the human fibrinogen gene cluster
Functionally related genes and their regulatory sequences tend to be arranged in the same regulatory domain [35] . Chromatin looping between the extremities of the fibrinogen gene cluster is inferred by CTCF interaction sites detected by ChIP-seq (chromatin immunoprecipitationsequencing) and CTCF ChIA-PET (chromatin interaction analysis by paired-end tag sequencing) signals [30] . Knowing the regulatory landscape of the fibrinogen locus ( Fig. 1A ) and in order to explain the co-regulation of the three fibrinogen genes, we aimed to detect chromatin interactions between regulatory elements of the gene cluster using chromosome conformation capture (3C) in a fibrinogen-expressing hepatocellular carcinoma cell line (HepG2) and a non-expressing human embryonic kidney cell line (HEK-293T).
A representation of the genomic region targeted for 3C is shown in Fig. 1(B) . Numbers represent regulatory fragments that were obtained after NlaIII fragmentation of crosslinked chromatin. The CTCF0-bearing restriction fragment, found upstream of FGB, was used as the 'bait' for this analysis, and qPCRs were used to detect proximity between it and 29 restriction fragments across the gene cluster, concentrating on known enhancers, CTCF interaction sites and control fragments. As expected, selfligation products and close linear proximity contribute to a peak found at and around the CTCF0 position in HepG2 and HEK-293T cells. A clear interaction is also detected between CTCF0 and CTCF4 at the other end of the locus in both cell types ( Fig. 1C and D) . This is reminiscent of interactions described by ChIA-PET in other cell types [30] and suggests a looping out of the fibrinogen gene cluster. In HepG2 cells, which produce fibrinogen, we also detected an interaction between CTCF0 and the FGA promoter. This interaction was detectable but of lower frequency in HEK-293T cells ( Fig. 1C and D) , suggesting that frequency of this internal interaction correlates with fibrinogen expression.
Targeted disruption of a chromatin interaction affects fibrinogen expression
To investigate whether the fibrinogen locus architecture is important for gene expression, we designed a loss-offunction experiment in which CTCF3 and CTCF4 sites, flanking one edge of the fibrinogen gene cluster, were deleted using CRISPR-Cas9 genome editing [31] ( Fig. 2A, Figures S1 and S2 ). We reasoned that this **** **** **** **** **** ** **** **** **** **** **** *** *** ** ** ** Absolute Quantification mRNA expression and specific HDR-directed deletions of the CTCF factorbook motif sequences [29] of CTCF3 (DCTCF3) and CTCF4 (DCTCF4). Double CTCF site deletion cell lines were also generated (DCTCF3/DCTCF4) ( Figures  S1 and S2) .
We measured chromatin interactions in the CTCF sitedeleted clones, using 3C and the CTCF0 site as bait. A DCTCF3 clone showed a similar interaction frequency profile to HepG2 cells. However, in DCTCF4 and DCTCF3/DCTCF4 clones, the HepG2 cluster looping interaction of CTCF0 with CTCF4 was lost (Fig. 2B) . With loop disruption, the CTCF0 to FGA promoter interaction was less frequently detected, and a previously undetected interaction between CTCF0 and PFE2 was observed. In DCTCF4 cells, an interaction between CTCF0 and CTCF3 was also detected, suggestive of cluster loop maintenance and reorganization. However, this was not sufficient to sustain the CTCF0 to FGA promoter interaction, pointing towards the CTCF4 site having a determinant role in the relative frequency of the CTCF0 to FGA promoter interactions.
We studied the effect of CTCF site deletion on fibrinogen expression. Fibrinogen mRNAs were quantified by qRT-PCR in HepG2 cells and CTCF site deletion clones (Fig. 2C) . The DCTCF3 cells showed mRNA levels of the three fibrinogen genes that were comparable with HepG2 cells. In DCTCF4 and DCTCF3/DCTCF4 clones, FGB and FGG mRNA levels were reduced compared to HepG2 cells. FGA mRNA levels remained unaffected in all deleted clones (Fig. 2C) .
As transcripts to sub-units of secreted hexameric fibrinogen, lowered mRNA levels of any of the fibrinogen transcripts should reduce fibrinogen protein production. We measured fibrinogen levels in cell-conditioned medium from HepG2 cells and CTCF site deletion clones, using data from a fibrinogen ELISA assay normalized to total cellular protein. Fibrinogen protein output was halved in DCTCF4 and DCTCF3/DCTCF4 clones compared with HepG2 cells. DCTCF3 cells were phenotypically similar to HepG2 cells in chromatin interactions, mRNA levels and protein production (Fig. 2D) . These data indicate that disruption of the fibrinogen locus CTCF4 interaction site, which is detected in proximity to CTCF0, affects FGB and FGG expression and lowers fibrinogen protein production.
Introducing a CTCF interaction site at the CTCF4 position rescues fibrinogen expression in DCTCF4 or DCTCF3/ DCTCF4 cells After detecting a loss-of-function effect for deletion of the fibrinogen locus CTCF4 site, we tested the specificity of this effect by using CRISPR-Cas9 tools to reintroduce CTCF3 and CTCF4 interaction motifs, in the previously engineered cell lines where they were deleted. Deletion of these sites produced unique sequences in the genome for which we designed sgRNAs to guide Cas9-mediated dsDNA cleavage, in the presence of an HDR oligonucleotide template for repair. We did not reintroduce the original HepG2 genomic sequence but rather each complete factorbook [29] interaction motif with four nucleotides on each side (Fig. 3A) . This enabled unambiguous identification of reintroduced motifs in potential phenotypic 'rescue' clones, while re-establishing the predicted functional CTCF interaction sequences. A description of this targeting is given in Figures S1 and  S2 .
The 3C experiments on CTCF site-rescued clones showed a locus boundary interaction between CTCF0 and CTCF4 in both DCTCF4R (R for rescue) and DCTCF3R/DCTCF4R cells (Fig. 3B) . The CTCF0 to FGA promoter interaction was also restored, with the overall 3C data resembling those of HepG2 cells. Fibrinogen mRNA and protein production were then assessed in the CTCF interaction site-rescued cells. By qRT-PCR, FGB, FGA and FGG mRNA were at HepG2 cell levels in DCTCF4R and DCTCF3R/DCTCF4R cells (Fig. 3C) . Fibrinogen protein production from these cells was also restored to HepG2 levels (Fig. 3D) .
Using loss-and restoration-of-function approaches, our results demonstrate that a chromatin interaction between the edges of the fibrinogen gene cluster, mediated by the CTCF4 interaction motif and the CTCF0 region, contributes to coordinated expression of the fibrinogen genes Fig. 1(C) , copied here to help compare interaction plots. Clones in which the CTCF4 interaction motif was deleted show a less frequent interaction between CTCF0 and the FGAp, although the overall chromosome domain was maintained with a novel interaction detected between CTCF0 and CTCF3. Data were normalized with the GAPDH gene for each ligation product. Error bars show standard error of the mean (SEM), n = 5 in HepG2 cells and n = 3 for each motif-deleted clone analyzed in the study. Each ligation product was analysed in triplicate. (C) Steady-state mRNA levels of fibrinogen gene expression (FGB, FGA and FGG) quantified in HepG2 cells and CTCF motif-deleted clones by qRT-PCR. Every dataset represents a unique clone (ΔCTCF3 = 1, ΔCTCF4 = 3, ΔCTCF3 + 4 = 3). Data were normalized with expression of b-actin. Note the reduction in FGB and FGG expression in all clones lacking CTCF4 (DCTCF4 and DCTCF3/DCTCF4 cells). Two-tailed Student's t-test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001. Error bars show SEM, n = 3. (D) ELISA quantification of fibrinogen production in HepG2 cells and CTCF motif-deleted cells, demonstrating a halving of fibrinogen levels in DCTCF4 cells with respect to HepG2 cells. Data were normalized to HepG2 fibrinogen levels. Two-tailed Student's t-test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001. Error bars show SEM, n = 3. Inflammatory stimuli can modulate fibrinogen expression. Previous studies have focused on cytokinemediated transcriptional regulation of fibrinogen genes [6] . IL-6 can increase fibrinogen gene expression [36, 37] . We aimed to assess chromatin interactions and fibrinogen expression under inflammatory conditions. We treated HepG2 cells and ΔCTCF4 cells with IL-6, TNF-a and endotoxin (LPS). Chromatin interactions at the fibrinogen locus were similar in IL-6-treated and untreated cells. This was true for HepG2 and DCTCF4 cells (Fig. 4A-B) . Both cell types responded to IL-6 treatment, with increases in fibrinogen mRNA and protein levels compared to untreated cells (Fig. 4C-D) . We conclude that changes in local chromatin interactions are not a major feature of the fibrinogen locus response to IL-6 signalling. We did not detect significant differences in chromatin interactions in either cell type after treatment with TNF-a or LPS. However, mRNA and protein levels were reduced after treatment with TNF-a ( Fig. 4C-D ), in agreement with previous studies [38] .
Discussion
The major finding of our study is that the human fibrinogen locus has a looped configuration that is functionally linked to fibrinogen gene expression. Using 3C methodology, we detected local chromatin interactions at the fibrinogen locus in HepG2 cells that express fibrinogen and HEK-293T cells that do not. The fibrinogen cluster is a regulatory unit where flanking CTCF sites are in proximity, creating a cluster-length chromatin loop. Using one of these sites as a constant anchoring fragment for our analyses (CTCF0), we were able to identify a loop interaction with the other site (CTCF4) in both cell types. However, we detected a difference in an internal chromatin interaction between fibrinogen-expressing (HepG2) and non-expressing cells (HEK-293T), with a higher frequency looping-in of the FGA promoter region towards CTCF0 in cells that produce fibrinogen. We interpret this as an interaction that facilitates the co-regulation of the fibrinogen genes, bringing regulatory elements into proximity. In a configuration where the FGA promoter is near CTCF0, it is also presumably closer to the E4 enhancer element. Even without the FGA promoter to CTCF0 interaction, the larger cluster loop (CTCF0 to CTCF4) 'pulls' the E3 and E4 enhancers closer together than in the linear configuration, and leaves them well placed to influence expression from nearby FGB and FGG promoters. The cluster looping we describe occurs in non-fibrinogen-expressing cells. Therefore it is not the cause of expression and more likely represents a structural chromatin unit. The expression of fibrinogen presumably relies on the complement of transcription factors and histone modifications at the locus in hepatocytes. However, we were intrigued to know what would happen to fibrinogen expression if the frequency of the cluster looping were lessened. Would fibrinogen gene expression be sensitive to the structural configuration of this chromatin unit?
We used CRISPR-Cas9 technology to delete two CTCF interaction sites at one end of the fibrinogen locus in HepG2 cells. These CTCF sites were chosen because they were seen as interaction partners for the other end of the cluster in data from the ENCODE project [30] , albeit in non-fibrinogen-expressing cells. As expected, deleting CTCF4's CTCF motif disabled its interaction with CTCF0, but also led to a novel interaction of CTCF0 with CTCF3 and lowering of the CTCF0 to FGA promoter interaction frequency. Despite the new loop between CTCF0 and CTCF3, fibrinogen expression was halved, suggesting that the CTCF0 to CTCF4 contact contributes more productively to fibrinogen expression, perhaps with a more optimal configuration of regulatory elements. The source of the lower fibrinogen protein production in DCTCF4 cells appears to come from lower steady-state expression of FGB and FGG transcripts, with FGA expression unaffected. FGA   Fig. 3. Introducing a CCCTC-binding 
template were used to reintroduce the CTCF factorbook motif of CTCF3 or CTCF4 in previously deleted clones. We designed a repair oligo template containing 15 nucleotides corresponding to the factorbook motif and four extra nucleotides on each side. Obtained rescue sequences are unique in the genome (*). (B) Chromatin interactions were measured by 3C in CTCF motif-deleted cells after reintroduction of the CTCF interaction site(s), using CTCF0 as the constant fragment. Interactions between CTCF0 and CTCF4 resemble closely those in HepG2 cells when the CTCF motif was reintroduced at the CTCF4 position. The chromatin interaction between CTCF0 and the FGA promoter was also rescued. Data were normalized with the GAPDH gene for each ligation product; error bars show SEM, n = 5 in HepG2 cells and n = 3 for each rescued clone analyzed in the study. Each ligation product was analysed in triplicate. Fibrinogen mRNA (C) and protein production (D) were restored to HepG2 levels when the CTCF motif was reintroduced at the CTCF4 position (DCTCF4R or DCTCF3R/DCTCF4R). For ease of comparison, control HepG2 data from Figs. 1 and 2 are copied into this figure for the chromatin interactions detected in HepG2 cells and the mRNA expression and protein production data for HepG2 cells. Error bars show standard error of the mean (SEM), n = 3. Interestingly, RAD21, a component of the cohesin complex involved in the formation of local chromatin interactions, is one of the transcription factors that bind the FGA promoter but not the FGB or FGG promoters [23, 30] . This could explain why the FGA promoter is looping with CTCF0 and CTCF4.
Deletion of nucleotides in our DCTCF motif cell lines was aimed at revealing a loss-of-function phenotype. Engineering these cells by reintroducing the CTCF interaction sites, gave us clear restoration-of-function effects: rescue of the CTCF0 to CTCF4 interaction and HepG2 cell fibrinogen expression levels. By manipulating CTCF3 and CTCF4 individually or together, our data unambiguously demonstrate the importance of the CTCF0 to CTCF4 interaction for fibrinogen expression. Despite subtle differences in the chromatin interaction profile of the fibrinogen locus in DCTCF4 vs. DCTCF3/DCTCF4 cells, fibrinogen expression was similarly affected and no effect was detected in DCTCF3 cells.
Our data have limitations. The 3C method provides information on contact frequencies between known chromatin segments in cell populations but does not provide information on the situation in individual cells. Also, the high number of cells needed for 3C experiments makes it unfeasable to use primary hepatocytes, whose expansion in vitro is challenging [39] . Figure 5 summarizes, using graphical representations, an overview of our interpretation of the chromatin interactions we have measured in HepG2 cells and after CTCF motif deletion or restoration, based on the frequency of interactions. In order to address this dynamic aspect of chromosome organization, single-cell analyses would be pertinent. Also, thus far, we have not assessed chromatin interactions of the fibrinogen locus in an intact organism; rather, we focused on the human gene cluster in a cellular model, which may show subtle mechanistic differences to hepatocytes in vivo. We did not functionally assess all the interactions we measured. Our data highlight an interaction between CTCF0 and CTCF6, a site telomeric to CTCF4 that has an interaction frequency with CTCF0 generally lower than that with CTCF4 in the cell lines described. We did not disrupt CTCF6 because its orientation with respect to CTCF0 does not fit the criteria for an interaction with CTCF0. The vast majority of CTCF site interaction pairs detected genome wide have their CTCF motifs in the convergent orientation as for CTCF0 and CTCF4 [12, 40] . CTCF0 and CTCF6 do not show this orientation. The effect of CTCF6 disruption may be additive to loss of the CTCF0 to CTCF4 interaction. Although we have measured lower fibrinogen gene expression in DCTCF4 cells that can be attributed to changes in chromatin architecture, this effect may also relate to an altered balance of active and repressive histone marks, as described for the bglobin locus upon conditional deletion of CTCF [22] . To better understand how the 3D architecture of chromatin is associated with the mechanism of gene expression, changes in chromatin organization must be correlated with other epigenetic effects, such as binding of transcription factors, architectural proteins or histone modifications.
Finally, we examined chromatin interactions and fibrinogen expression in HepG2 cells and ΔCTCF4 cells after inflammatory stimuli. In both cell types, mRNA levels of the three fibrinogen genes were significantly increased after treatment with IL-6. This is in agreement with previous studies in which IL-6 stimulates a coordinate increase in fibrinogen mRNA [6, 41] . Fibrinogen was decreased after TNF-a treatment, as previously reported [38] . LPS treatment did not affect fibrinogen levels.
We did not detect major changes in the chromatin architecture of the fibrinogen gene cluster in response to IL-6 or TNF-a, in HepG2 or ΔCTCF4 cells. Therefore, at the resolution of our assays, cytokines that increase or decrease fibrinogen production via changes in steady-state mRNA levels do not have their effects mediated by modification of chromatin interactions.
We have demonstrated that local chromatin contacts occur at the fibrinogen gene cluster and contribute to fibrinogen gene expression and protein output. This links chromatin architecture to the production of a clinically important blood clotting factor, revealing a regulatory Fig. 4 . Chromatin interactions and fibrinogen expression after treatment with IL-6, TNF-a and lipopolysaccharide (LPS). Chromatin interactions at the fibrinogen gene cluster without inflammatory stimuli and after treatment with IL-6, TNF-a and LPS in (A) HepG2 cells and (B) ΔCTCF4 cells. (C) FGB, FGA and FGG mRNA levels are significantly increased after treatment with IL-6 in HepG2 and ΔCTCF4 cells. In contrast, mRNA levels of the three fibrinogen genes are significantly reduced in HepG2 and ΔCTCF4 cells after treatment with TNF-a. Treatment with LPS did not show any significant changes in fibrinogen mRNA levels. Two-tailed Student's t-test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001, compared to non-treated HepG2 cells. Two-tailed Student's t-test, # P ≤ 0.05, ## P ≤ 0.01, ### P ≤ 0.001 and #### P ≤ 0.0001, compared to non-treated ΔCTCF4 cells. Error bars show standard error of the mean (SEM), n = 3. (D) Fibrinogen protein levels were significantly increased in HepG2 and ΔCTCF4 cells after treatment with IL-6. In agreement with mRNA levels, protein levels were also significantly reduced in HepG2 and ΔCTCF4 after treatment with TNF-a. Treatment with LPS did not show significant differences. Twotailed Student's t-test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001, compared to non-treated cells. Error bars show SEM, n = 3. CTCF, CCCTC-binding factor.
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